All market and epidemiological figures in this document are sourced from peer-reviewed research, official NHS/ONS publications, or published market research reports. Year 1 financial projections (sources 6) are internal targets based on freemium conversion benchmarks in comparable health apps and are not guaranteed forecasts. Insight engine example figures (−1.8 mmol/L, +1.3 mmol/L) are illustrative of the type of correlation the engine surfaces — not published clinical claims.
1
12M UK adults with diabetes or prediabetes (4.6M diagnosed, 1.3M undiagnosed, 6.3M prediabetes)
Diabetes UK, February 2025. "One in five adults now live with diabetes or prediabetes in the UK."
diabetes.org.uk →
2
Global diabetes apps market: £25.3B by 2032, 15.5% CAGR (2025–2032)
Coherent Market Insights, 2025. "Diabetes Apps Market Size & Opportunities, 2025–2032." Converted from USD $31.6B at April 2026 exchange rate. Market research estimate — range varies by analyst
3
5–10% of prediabetics progress to Type 2 diabetes annually
The Lancet Diabetes & Endocrinology, February 2025. "Prediabetes: much more than just a risk factor." doi:10.1016/S2213-8587(25)00034-8. Also cited in NHS DPP scoping reviews (PMC9321029).
4
Individual glucose responses to identical foods vary significantly between people
Zeevi D. et al. (2015). "Personalized Nutrition by Prediction of Glycemic Responses." Cell, 163(5), 1079–1094. doi:10.1016/j.cell.2015.11.001. This is the foundational paper establishing personal glycaemic variability.
5
Poor or short sleep is associated with higher fasting blood glucose levels
Reutrakul S. & Van Cauter E. (2018). "Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes." Metabolism, 84, 56–66. doi:10.1016/j.metabol.2018.02.010. Direction of correlation well established; magnitude is personal
6
Year 1 targets: 50,000 users, 8,000 paid subscribers, £384K ARR
Internal projection. 50K total users at 16% paid conversion = 8K subscribers. 8K × £3.99/mo × 12 = £383K ARR. Freemium conversion benchmarks drawn from comparable health app cohorts (MySugr reported ~3M registered users with ~30% active). Forward-looking projection — not a guarantee
7
Insulin resistance affects 35–80% of women diagnosed with PCOS
Sirmans S.M. & Pate K.A. (2014). "Epidemiology, diagnosis, and management of polycystic ovary syndrome." Clinical Epidemiology, 6, 1–13. doi:10.2147/CLEP.S37559. Also supported by NIH publication March 2022 (PMC cited in Fortune Business Insights PCOS market report).
8
73% of GP practices in England were not adequately coding or managing prediabetic patients
NHS Digital report, 2017. Cited in: Gillies C. et al. (2022). "The English national health service diabetes prevention programme (NHS DPP): A scoping review." PMC9321029.
PMC → 2017 data — coding practices have improved since
9
UK government commits £600M to Health Data Research Service
Wellcome Trust / UK Government announcement, April 2025. "National data service will simplify access to health data for research."
wellcome.org →. Also reported in Pharmaphorum, April 2025.
A note on the "0 apps" claim (removed): We removed the previous claim that "0 apps combine food intelligence and a personal insights engine" as this is subjective and hard to substantiate definitively. What we can accurately say is that no leading competitor (MySugr, Glooko, One Drop, Libre-linked apps) currently offers cross-stream personal correlation analysis of the type carbIQ provides. This remains a genuine product differentiation.